1. Hamblin MR: History and mechanisms of photobiomodulation, with a focus on treatment of brain disorders. Book of abstracts for podium presentations, PBM2021 joint NAALTWALT conference, October 1–3, 2021, 3. https://www.pbm2021.com/program. Stand: 7.10.2021.
2. Chow R: What does it take to achieve recognition as a mainstream therapy? — a commentary. Book of abstracts for podium presentations, PBM2021 joint NAALT-WALT conference, October 1–3, 2021, 30. https://www.pbm2021.com/program. Stand: 7.10.2021.
3. Carroll J: Photobiomodulation: the roadmap to mainstream acceptance. Book of abstracts for podium presentations, PBM2021 joint NAALT-WALT conference, October 1–3, 2021, 31. https://www.pbm2021.com/program. Stand: 7.10.2021.
4. Ailioaie LM, Litscher G: Molecular and cellular mechanisms of arthritis in children and adults: new perspectives on applied photobiomodulation. Int J Mol Sci. 2020; 21: 6565. doi:https://doi.org/10.3390/ijms21186565, IF=5.923.
5. Ailioaie LM, Litscher G: Curcumin and photobiomodulation in chronic viral hepatitis and hepatocellular carcinoma. Int J Mol Sci 2020; 21: 7150. doi:https://doi.org/10.3390/ijms21197150, IF=5.923.